A Dose-finding Phase I Study of F8IL10 Intra-articular Treatment in Rheumatoid Arthritis
Latest Information Update: 21 Nov 2022
At a glance
- Drugs F8 IL10 (Primary)
- Indications Rheumatoid arthritis
- Focus Adverse reactions
- Acronyms DekaJoint
- Sponsors Philogen
- 21 Nov 2022 New trial record